Dexrazoxaan bij anthracycline-geïnduceerde cardiotoxiciteit en anthracycline-extravasatie.

Pharmacology, Toxicology and Pharmaceutical Science

• Anthracycline 100%
• Cardiotoxicity 100%
• Extravasation 100%
• Razoxane 100%
• Clinical Study 25%
• Side Effect 12%
• Injury 12%
• Adverse Event 12%
• Thrombocytopenia 12%
• Leukopenia 12%
• Randomized Clinical Trial 12%
• Congestive Heart Failure 12%

Keyphrases

• Anthracycline-induced Cardiotoxicity 100%
• Dexrazoxane 100%
• Anthracyclines 37%
• Cardioprotective Agents 37%
• Cardiac Events 12%
• Heart Failure 12%
• Oxidative Stress 12%
• Randomized Clinical Trial 12%
• Cardiotoxicity 12%
• Adverse Effects 12%
• Surgical Resection 12%
• Secondary Malignancy 12%
• Antitumor Effect 12%
• Thrombocytopenia 12%
• Leukopenia 12%
• Serious Complications 12%
• Local Reaction 12%
• Anthracycline Extravasation 12%
• Event Failure 12%
• Extravasation Injury 12%
• Infusion Site 12%